2012
DOI: 10.1016/j.cllc.2011.11.002
|View full text |Cite
|
Sign up to set email alerts
|

International Practice Survey on Palliative Lung Radiotherapy: Third International Consensus Workshop on Palliative Radiotherapy and Symptom Control

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
22
0

Year Published

2012
2012
2018
2018

Publication Types

Select...
5
2

Relationship

1
6

Authors

Journals

citations
Cited by 25 publications
(22 citation statements)
references
References 47 publications
0
22
0
Order By: Relevance
“…[4][5][6][7][8] Although this may simply reflect provider and patient preferences or differences in clinical scenarios, prior studies suggest that providers not only may be overly optimistic about patient prognosis but may also have difficulty communicating prognosis to patients with terminal cancer. [9][10][11][12] In addition, considerable evidence suggests that patients with cancer may hold unrealistic beliefs about prognosis and the potential efficacy of treatment.…”
Section: Introductionmentioning
confidence: 99%
“…[4][5][6][7][8] Although this may simply reflect provider and patient preferences or differences in clinical scenarios, prior studies suggest that providers not only may be overly optimistic about patient prognosis but may also have difficulty communicating prognosis to patients with terminal cancer. [9][10][11][12] In addition, considerable evidence suggests that patients with cancer may hold unrealistic beliefs about prognosis and the potential efficacy of treatment.…”
Section: Introductionmentioning
confidence: 99%
“…To the contrary, in patients with a poor PS and short expected survival time, hypofractionated short-course PTR is used most frequently [1,[3][4][5][6]11,[14][15][16][17][20][21][22][23]. In terms of relief of symptoms associated with locally growth of NSCLC, shorter courses of PTR are as effective as more protracted regimens [1,4,5,11,[14][15][16][17][23][24][25][26].…”
Section: Introductionmentioning
confidence: 99%
“…In these patients, the question whether to offer radiotherapy or not should be considered rather than the issue of fractionation schedule. The main factors that influence this decision are: performance status, estimated prognosis, symptom severity and patient's choice [1,3,10,13,14,18,19,27,28].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…The authors found that there was a greater likelihood of symptom improvement and a modest benefit in overall survival with radiotherapy schedules of 35 Gy 10 BED (i.e., 30 Gy in ten fractions) or greater. These findings informed various consensus papers including the American Society for Radiation Oncology (ASTRO) practice guideline [21], and an international consensus statement [22]. The general recommendations from the above reviews and guidelines are that radiotherapy schedules of 35Gy 10 BED (i.e., 30 Gy in ten fractions) or greater should be considered for patients with good performance status.…”
Section: External-beam Radiotherapymentioning
confidence: 99%